PCI Biotech and Immunicum Announce an Extension to Their Research Collaboration to Explore Novel Cancer Vaccination Treatments

NEXT STORY
Reliq Health Technologies, Inc. Files Q1 FY2022 Quarterly Financial Statements, Provides Corporate Update
PREV STORY
OSE Immunotherapeutics Provides an Update on the First Positive Results and Clinical Development of CoVepiT, its Multi-Target T-cell Anti-COVID Vaccine
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Calithera Biosciences Announces Clinical Data Presentations at ASCO 2016

SOUTH SAN FRANCISCO, Calif., April 21, 2016 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq:CALA) ...

author_avatar
NASDAQ Market News

ABOG Appoints New Chair and Members of Subspecialty Divisions

New Chair and Members Start on July 1Dallas, Feb. 14, 2019 (GLOBE NEWSWIRE) -- ...

author_avatar
NASDAQ Market News

aTyr Pharma Announces Fourth Quarter and Year-End 2017 Operating Results and Provides Corporate Update

SAN DIEGO, March 19, 2018 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq:LIFE), a biotherapeutics ...

author_avatar
NASDAQ Market News